Filtros de búsqueda

Lista de obras de Josef Smolen

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

scholarly article by Daniel Aletaha et al published 10 August 2010 in Arthritis and Rheumatism

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

artículo científico publicado en 2010

2016 update of the EULAR recommendations for the management of early arthritis ⬇️

artículo científico publicado en 2016

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

artículo científico publicado en 2019

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

scientific article published on 05 August 2019

A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study

artículo científico publicado en 2016

A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content

artículo científico publicado en 2002

A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories.

artículo científico publicado en 2003

A dynamic real time in vivo and static ex vivo analysis of granulomonocytic cell migration in the collagen-induced arthritis model

artículo científico publicado en 2012

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).

artículo científico publicado en 2016

A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

artículo científico publicado en 2014

A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis

artículo científico publicado en 2009

A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis

artículo científico publicado en 2017

A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis

artículo científico publicado en 2011

A1.81 Mincle is not essential in T-cell independent arthritis models

ANA as an Entry Criterion in SLE Classification

artículo científico publicado en 2018

AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases

artículo científico publicado en 2008

Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis

artículo científico publicado en 2015

Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice

artículo científico publicado en 2005

Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone

artículo científico publicado en 2017

Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells

artículo científico publicado en 2009

Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease

artículo científico publicado en 2008

Activity assessments in rheumatoid arthritis

artículo científico publicado en 2008

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

artículo científico publicado en 2005

Adalimumab - a new TNF-alpha antibody for treatment of inflammatory joint disease

artículo científico publicado en 2003

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

artículo científico publicado en 2013

Advances in targeted therapies XIV ⬇️

artículo científico publicado el 1 de abril de 2013

Advances in targeted therapy

artículo científico publicado en 2016

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials ⬇️

artículo científico publicado en 2011

An intergenerational program based on psycho-motor activity promotes well-being and interaction between preschool children and older adults: results of a process and outcome evaluation study in Austria

artículo científico publicado en 2019

Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations

scientific article published on 01 January 2008

Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement

artículo científico publicado en 2009

Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis

article

Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation

artículo científico publicado en 2004

Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?

artículo científico publicado en 2006

Assessment of Global Disease Activity in Rheumatoid Arthritis by Patients and Physicians: Differences Across Countries in the METEOR Database

artículo científico publicado en 2015

Association of anemia and physical disability among patients with rheumatoid arthritis.

artículo científico publicado en 2007

Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate ⬇️

artículo científico publicado el 22 de agosto de 2012

Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in meth

artículo científico publicado en 2015

Autoantibodies in rheumatoid arthritis and their clinical significance

artículo científico publicado en 2002

Autoantigen microarrays for multiplex characterization of autoantibody responses

artículo científico publicado en 2002

B-cell infiltrates induce endosteal bone formation in inflammatory arthritis.

artículo científico publicado en 2008

B-cell targeted therapeutics in clinical development ⬇️

artículo científico publicado el 4 de abril de 2013

Baricitinib in Patients with Refractory Rheumatoid Arthritis

artículo científico publicado en 2016

Benefits and Sustainability of a Learning Collaborative for Implementation of Treat to Target in Rheumatoid Arthritis: Results of the TRACTION Trial Phase II.

artículo científico publicado en 2018

Biosimilar safety factors in clinical practice

artículo científico publicado en 2015

Biosimilars to treat inflammatory arthritis: the challenge of proving identity

artículo científico publicado en 2013

Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement

artículo científico publicado en 2013

Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis

artículo científico publicado en 2007

Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria

artículo científico publicado en 2016

CCR6 controls autoimmune but not innate immunity-driven experimental arthritis

artículo científico publicado en 2018

CD44 is a determinant of inflammatory bone loss

artículo científico publicado en 2005

CD4⁺CD25⁻Foxp3⁺ T cells: a marker for lupus nephritis?

artículo científico publicado en 2014

CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis

artículo científico publicado en 2015

Cadherin 11 promotes invasive behavior of fibroblast-like synoviocytes

artículo científico publicado en 2009

Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example

artículo científico publicado en 2014

Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients

artículo científico publicado en 2015

Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial

artículo científico publicado en 2011

Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years

scientific article published on 27 June 2011

Clinical meaning and implications of serum hemoglobin levels in patients with rheumatoid arthritis

artículo científico publicado en 2017

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease

artículo científico publicado en 2016

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA s

artículo científico publicado en 2012

Clocking in: chronobiology in rheumatoid arthritis

artículo científico

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

artículo científico publicado en 2004

Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis ⬇️

artículo científico publicado el 29 de octubre de 2010

Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis ⬇️

artículo científico publicado el 30 de enero de 2012

Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results

artículo científico publicado en 2017

Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis

artículo científico publicado en 2008

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions

artículo científico publicado en 2012

Contribution of Genetic Factors to Lower DHEAS in Patients with Rheumatoid Arthritis

artículo científico publicado en 2017

Contributions of ultrasound beyond clinical data in assessing inflammatory disease activity in rheumatoid arthritis: current insights and future prospects

artículo científico publicado en 2014

Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study ⬇️

artículo científico publicado en 2018

Correction: Interleukin-6: a new therapeutic target.

artículo científico publicado en 2006

Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis

artículo científico publicado en 2002

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

artículo científico publicado en 2010

Cytokines as therapeutic targets: advances and limitations

artículo científico publicado en 2008

Daily functioning and health status in patients with hand osteoarthritis: Fewer differences between women and men than expected

artículo científico publicado en 2011

Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index ⬇️

artículo científico publicado el 27 de marzo de 2012

Determinants of Patient-Physician Discordance in Global Assessment in Psoriatic Arthritis: A Multicenter European Study

artículo científico publicado en 2016

Determinants of sleep impairment in psoriatic arthritis: an observational study with 396 patients from 14 countries

scientific article published on 10 April 2020

Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.

artículo científico publicado en 2018

Developing an effective treatment algorithm for rheumatoid arthritis

artículo científico publicado en 2012

Developing and Refining New Candidate Criteria for Systemic Lupus Erythematosus Classification: An International Collaboration

artículo científico

Development and validation of modified disease activity scores in rheumatoid arthritis: superior correlation with magnetic resonance imaging-detected synovitis and radiographic progression

artículo científico publicado en 2014

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology ⬇️

artículo científico publicado en 2014

Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohort

artículo científico publicado en 2015

Development of a new occupational balance-questionnaire: incorporating the perspectives of patients and healthy people in the design of a self-reported occupational balance outcome instrument

artículo científico publicado en 2014

Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-project

artículo científico publicado en 2015

Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project

artículo científico publicado en 2013

Developments in the clinical understanding of rheumatoid arthritis

artículo científico publicado en 2009

Diagnosis and Management of Rheumatoid Arthritis: A Review

artículo científico publicado en 2018

Dickkopf-1 is a master regulator of joint remodeling

artículo científico publicado en 2007

Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis

artículo científico publicado en 2006

Differentially regulated expression of growth differentiation factor 5 and bone morphogenetic protein 7 in articular cartilage and synovium in murine chronic arthritis: potential importance for cartilage breakdown and synovial hypertrophy

artículo científico publicado en 2008

Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity

artículo científico publicado en 2016

Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review

artículo científico

Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials

scientific article published on 10 November 2019

Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score

artículo científico publicado en 2015

Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: Involvement of impaired integrin activation and immunologic synapse formation

artículo científico publicado en 2005

Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference

artículo científico publicado en 2015

Documentation of off-label use of biologics in Rheumatoid Arthritis ⬇️

artículo científico publicado el 1 de abril de 2013

Does mixed connective tissue disease exist? Yes

artículo científico publicado en 2005

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunog

artículo científico publicado en 2018

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide

artículo científico publicado en 2015

EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria

artículo científico publicado en 2013

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

artículo científico publicado en 2012

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

artículo científico publicado en 2010

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

artículo científico publicado en 2014

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

artículo científico publicado en 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

artículo científico publicado en 2020

EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis

artículo científico publicado en 2013

Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis ⬇️

artículo científico publicado el 18 de enero de 2012

Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

scientific article published on 06 May 2010

Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate

artículo científico publicado en 2016

Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis

artículo científico publicado en 2009

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

artículo científico publicado en 2008

Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study.

artículo científico publicado en 2002

Effects of 18β-Glycyrrhetinic acid in hTNFtg mice – a model of rheumatoid arthritis ⬇️

artículo científico publicado el 3 de enero de 2012

Effects of a brief workplace-centered consultation for employees with musculoskeletal pain on health outcomes: a prospective cohort study

article

Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

artículo científico publicado en 2016

Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial

artículo científico publicado en 2016

Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind stud

artículo científico publicado en 2015

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

artículo científico publicado en 2017

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

artículo científico

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

artículo científico publicado en 2017

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

artículo científico publicado en 2014

Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

artículo científico publicado en 2017

Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology

scientific article published on 20 April 2020

Endothelial precursor cells in the synovial tissue of patients with rheumatoid arthritis and osteoarthritis

artículo científico publicado en 2004

Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy

artículo científico publicado en 2007

Environmental arginine controls multinuclear giant cell metabolism and formation

artículo científico publicado en 2020

Era of biosimilars in rheumatology: reshaping the healthcare environment.

artículo científico publicado en 2019

Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice

artículo científico publicado en 2011

Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials

artículo científico publicado en 2009

Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis

artículo científico publicado en 2009

Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review

artículo científico publicado en 2010

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

artículo científico publicado en 2010

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update ⬇️

artículo científico

Existing joint erosions increase the risk of joint space narrowing independently of clinical synovitis in patients with early rheumatoid arthritis

artículo científico publicado en 2015

Expanding the frontiers of therapy

artículo científico publicado en 2006

Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008.

artículo científico publicado en 2009

Forget personalised medicine and focus on abating disease activity ⬇️

artículo científico publicado el 7 de noviembre de 2012

Future of RA: building on what we know and tailoring treatment ⬇️

artículo científico publicado el 1 de julio de 2012

GRAPPA-OMERACT consensus-based recommendations and research agenda for use of composite measures and treatment targets in PsA. ⬇️

artículo científico publicado en 2017

Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis

artículo científico publicado en 2010

Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics Trials

artículo científico publicado en 2016

Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study

artículo científico publicado en 2015

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

artículo científico publicado en 2009

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

artículo científico publicado en 2012

Greetings from the editor 2021

artículo científico publicado en 2021

HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus: correlations with clinical and autoantibody subsets

artículo científico publicado en 2002

Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study

artículo científico publicado en 2016

Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing

scientific article published on 31 January 2013

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

artículo científico publicado en 2022

Histopathological correlation supports the use of x-rays in the diagnosis of hand osteoarthritis ⬇️

artículo científico publicado el 12 de mayo de 2012

Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.

artículo científico publicado en 2016

How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion

artículo científico publicado en 2002

I have mastered the challenge of living with a chronic disease: life stories of people with rheumatoid arthritis

artículo científico publicado en 2008

Identification of relevant concepts of functioning in daily life in people with systemic lupus erythematosus: A patient Delphi exercise

scientific article published on 01 January 2009

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative

artículo científico publicado en 2019

IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis

artículo científico publicado en 2006

Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis

artículo científico publicado en 2006

Immediate access rheumatology clinic: efficiency and outcomes ⬇️

artículo científico publicado el 11 de octubre de 2011

Immunodominant T-cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritis.

artículo científico publicado en 2010

Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study

artículo científico publicado en 2016

Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis.

artículo científico publicado en 2018

Impairment of chondrocyte biosynthetic activity by exposure to 3-tesla high-field magnetic resonance imaging is temporary

artículo científico publicado en 2006

Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial

artículo científico publicado en 2017

Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trial

artículo científico publicado en 2016

Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)

Increased expression of discoidin domain receptor 2 is linked to the degree of cartilage damage in human knee joints: a potential role in osteoarthritis pathogenesis

artículo científico publicado en 2007

Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial

Inflammatory bone loss: pathogenesis and therapeutic intervention

artículo científico publicado en 2012

Infliximab in active early rheumatoid arthritis

artículo científico publicado en 2004

Infliximab: 12 years of experience ⬇️

artículo científico publicado el 25 de mayo de 2011

Information technology in rheumatology

artículo científico publicado en 2016

Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo

artículo científico publicado en 2009

Initial evidence for the link between activities and health: Associations between a balance of activities, functioning and serum levels of cytokines and C-reactive protein

artículo científico

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

artículo científico publicado en 2013

Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis

artículo científico publicado en 2005

Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis.

artículo científico publicado en 2012

Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis

artículo científico publicado en 2010

Interleukin-6: a new therapeutic target

artículo científico publicado en 2006

Interphalangeal Osteoarthritis Radiographic Simplified (iOARS) score: a radiographic method to detect osteoarthritis of the interphalangeal finger joints based on its histopathological alterations ⬇️

artículo científico publicado el 29 de julio de 2013

Is adalimumab in combination with methotrexate a safe and efficacious treatment for early rheumatoid arthritis?

artículo científico publicado en 2006

Is computer-assisted management necessary for patients with early rheumatoid arthritis?

artículo científico publicado en 2008

JNK1 is not essential for TNF-mediated joint disease

artículo científico publicado en 2004

Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints ⬇️

artículo científico publicado el 1 de diciembre de 2011

Leflunomide: a manageable safety profile.

artículo científico publicado en 2004

Lefunomide in combination therapy.

artículo científico publicado en 2004

Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature

artículo científico publicado en 2005

Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses.

artículo científico publicado en 2018

Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure ⬇️

artículo científico publicado el 1 de marzo de 2013

Management of psoriatic arthritis in 2016: a comparison of EULAR and GRAPPA recommendations

artículo científico publicado en 2016

Mapping hand functioning in hand osteoarthritis: comparing self-report instruments with a comprehensive hand function test

scientific article published on 01 October 2007

Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components

artículo científico publicado en 2006

Measuring functioning in patients with hand osteoarthritis--content comparison of questionnaires based on the International Classification of Functioning, Disability and Health (ICF).

artículo científico publicado en 2006

Measuring health in patients with fibromyalgia: content comparison of questionnaires based on the International Classification of Functioning, Disability and Health

artículo científico publicado en 2008

Mechanisms of Disease: the link between RANKL and arthritic bone disease

artículo científico publicado en 2005

Mechanisms of tissue damage in arthritis

artículo científico publicado en 2014

Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure

artículo científico publicado en 2006

Minimal disease activity for rheumatoid arthritis: a preliminary definition

artículo científico publicado en 2005

Mixed connective tissue disease: what is behind the curtain?

artículo científico publicado en 2007

Moberg picking-up test in patients with inflammatory joint diseases: a survey of suitability in comparison with button test and measures of disease activity

artículo científico publicado en 2003

Monitoring rheumatoid arthritis ⬇️

artículo científico publicado el 1 de mayo de 2011

Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus

artículo científico publicado en 2019

Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity

artículo científico

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis. ⬇️

artículo científico publicado en 2017

New insights in the mechanism of bone loss in arthritis

artículo científico publicado en 2005

New therapies for treatment of rheumatoid arthritis

artículo científico publicado en 2007

Objectives and strategies for rheumatoid arthritis therapy: yesterday vs. today.

artículo científico publicado en 2003

Occupational balance of women with rheumatoid arthritis: a qualitative study

artículo científico publicado en 2004

Opportunities and challenges in rheumatology research in Central Europe

artículo científico publicado en 2017

Osteoclasts are essential for TNF-alpha-mediated joint destruction

artículo científico publicado en 2002

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

artículo científico publicado en 2004

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice

artículo científico publicado en 2003

Overexpression of tumor necrosis factor causes bilateral sacroiliitis

artículo científico publicado en 2004

PTEN in antigen presenting cells is a master regulator for Th17-mediated autoimmune pathology

artículo científico publicado en 2012

Pathogenesis of rheumatoid arthritis: targeting cytokines

artículo científico publicado en 2005

Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells

artículo científico publicado en 2010

Patient Perspective on Remission in Rheumatoid Arthritis ⬇️

artículo científico publicado el 1 de agosto de 2011

Patient access to rheumatoid arthritis treatments

artículo científico publicado en 2008

Patient education, disease activity and physical function: can we be more targeted? A cross sectional study among people with rheumatoid arthritis, psoriatic arthritis and hand osteoarthritis ⬇️

artículo científico publicado en 2013

Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) study

artículo científico publicado en 2015

Perceptions of risk and predictive testing held by the first-degree relatives of patients with rheumatoid arthritis in England, Austria and Germany: a qualitative study

artículo científico publicado en 2016

Performance of Anti-nuclear Antibodies for Classifying Systemic Lupus Erythematosus: a Systematic Literature Review and Meta-regression of Diagnostic Data

artículo científico publicado en 2017

Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review ⬇️

artículo científico publicado el 16 de abril de 2013

Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

artículo científico publicado en 2020

Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes?

artículo científico publicado en 2002

Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis

scientific article published on 07 May 2020

Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis

artículo científico publicado en 2015

Pharmacotherapy: How well can we compare different biologic agents for RA?

artículo científico publicado en 2010

Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus

artículo científico publicado en 2009

Phosphatase and tensin homolog (PTEN) in antigen-presenting cells controls Th17-mediated autoimmune arthritis

artículo científico publicado en 2015

Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction

artículo científico publicado en 2011

Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis

artículo científico publicado en 2005

Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients

artículo científico publicado en 2015

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

artículo científico publicado en 2020

Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis

artículo científico publicado en 2020

Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologist.

artículo científico publicado en 2013

Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study

scholarly article by Josef S Smolen et al published 2019 in RMD open

Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases

scholarly article by Nicole Harrison et al published August 2018 in Vaccine

Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate

scholarly article by Josef S Smolen et al published November 2018 in Annals of the Rheumatic Diseases

Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial

artículo científico publicado en 2018

Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts

artículo científico publicado en 2018

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).

artículo científico publicado en 2013

Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects

artículo científico publicado en 2005

Progress toward the development of a new definition of remission in rheumatoid arthritis

artículo científico publicado en 2010

Proposal for a new nomenclature of disease-modifying antirheumatic drugs

artículo científico publicado en 2013

Putting patients first: the need for evidence-based and patient-centered standards of care in rheumatoid arthritis

article

Quality indicators in rheumatoid arthritis: results from the METEOR database

artículo científico publicado en 2015

Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).

artículo científico publicado en 2008

Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis

scientific article published on 14 August 2020

Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA.

artículo científico publicado en 2010

Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease

artículo científico publicado en 2015

Regulatory T cells form stable and long-lasting cell cluster with myeloid dendritic cells (DC) ⬇️

artículo científico publicado el 24 de febrero de 2012

Relationship between disease activity indices and their individual components and radiographic progression in RA: a systematic literature review

artículo científico publicado en 2014

Relevant concepts of functioning for patients with systemic lupus erythematosus identified in a Delphi exercise of experts and a literature review

artículo científico publicado en 2014

Reliability of patient-reported outcomes in rheumatoid arthritis patients: an observational prospective study

artículo científico publicado en 2015

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states

artículo científico publicado en 2005

Remission by composite scores in rheumatoid arthritis: are ankles and feet important?

artículo científico publicado en 2007

Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12.

artículo científico publicado en 2015

Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome

artículo científico publicado en 2011

Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs

artículo científico publicado en 2014

Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets

scientific article published on 01 November 2019

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis

artículo científico publicado en 2004

Reply

scholarly article

Reporting of long-term extension studies: lack of consistency calls for consensus

artículo científico publicado en 2011

Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper

artículo científico publicado en 2007

Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients

artículo científico publicado en 2009

Response to 'Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis'.

artículo científico publicado en 2015

Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis

artículo científico publicado en 2018

Response to: 'The time has come to revisit alternative interpretations of data underlying the EULAR management recommendations for rheumatoid arthritis' by Pirilä et al.

artículo científico publicado en 2017

Rheumatoid arthritis and falls: the influence of disease activity

artículo científico publicado en 2012

Rheumatoid arthritis in 2010: from the gut to the joint

scientific article published on February 2011

Rheumatoid arthritis near remission: clinical rather than laboratory inflammation is associated with radiographic progression ⬇️

artículo científico publicado el 28 de julio de 2011

Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade

artículo científico publicado en 2003

Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges

artículo científico publicado en 2015

Rheumatoid arthritis.

artículo científico publicado en 2016

Rheumatoid arthritis: where are we now? ⬇️

artículo científico publicado el 1 de julio de 2012

Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity ⬇️

artículo científico publicado el 13 de julio de 2012

Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials

artículo científico publicado en 2015

Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients

artículo científico publicado en 2012

SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus

artículo científico publicado en 2003

Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis

artículo científico publicado en 2017

Safety and efficacy of biosimilars in oncology

artículo científico publicado en 2016

Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study

artículo científico publicado en 2004

Safety of off-label biologicals in systemic lupus erythematosus

artículo científico publicado en 2014

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

artículo científico

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis

artículo científico publicado en 2017

Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis

artículo científico publicado en 2012

Serum leptin level and the risk of nontraumatic fracture

artículo científico publicado en 2004

Similar problem in the activities of daily living but different experience: a qualitative analysis in six rheumatic conditions and eight European countries

artículo científico publicado en 2013

Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction

artículo científico publicado en 2004

Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy

artículo científico publicado en 2014

Soluble RANKL and risk of nontraumatic fracture

artículo científico publicado en 2004

Sonographic joint assessment in rheumatoid arthritis: associations with clinical joint assessment during a state of remission

artículo científico publicado en 2013

Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction?

artículo científico publicado en 2005

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

scientific article published on 01 April 2005

Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial ⬇️

artículo científico publicado el 16 de mayo de 2012

Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture

article

Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation

artículo científico publicado en 2001

Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation

artículo científico publicado en 1999

TNF-induced structural joint damage is mediated by IL-1.

artículo científico publicado en 2007

Ten years of infliximab: insights from clinical trials in rheumatoid arthritis

artículo científico publicado en 2009

Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis

artículo científico publicado en 2007

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report

artículo científico publicado en 2010

The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care

artículo científico publicado en 2007

The Simplified Disease Activity Index and Clinical Disease Activity Index to monitor patients in standard clinical care

artículo científico publicado en 2009

The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis

artículo científico publicado en 2010

The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function

artículo científico publicado en 2005

The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel.

artículo científico publicado en 2011

The assessment of disease activity in rheumatoid arthritis.

scientific article published on May 2010

The changing landscape of biosimilars in rheumatology

artículo científico publicado en 2016

The definition and measurement of disease modification in inflammatory rheumatic diseases

artículo científico publicado en 2006

The effects of structural damage on functional disability in psoriatic arthritis

artículo científico publicado en 2017

The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.

artículo científico publicado en 2004

The eumusc.net standards of care for rheumatoid arthritis: importance and current implementation according to patients and healthcare providers in the Netherlands

artículo científico publicado en 2017

The health assessment questionnaire in routine clinical practice

artículo científico publicado en 2007

The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases

artículo científico publicado en 2007

The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs

artículo científico publicado en 2015

The importance of reporting disease activity states in rheumatoid arthritis clinical trials

artículo científico publicado en 2008

The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?

artículo científico publicado en 2008

The pathogenesis of rheumatoid arthritis: new insights from old clinical data? ⬇️

artículo científico publicado el 13 de marzo de 2012

The patient perspective on remission in rheumatoid arthritis: ‘You've got limits, but you're back to being you again’

artículo científico publicado en 2014

The public neglect of rheumatic diseases: insights from analyses of attendees in a musculoskeletal disease awareness activity

artículo científico publicado en 2007

The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review

artículo científico publicado en 2011

The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis

artículo científico publicado en 2007

The role of biosimilars in the treatment of rheumatic diseases

artículo científico publicado en 2012

The role of osteoprotegerin in arthritis

artículo científico publicado en 2003

The role of tumor necrosis factor-alpha in systemic lupus erythematosus

artículo científico publicado en 2008

The science of rheumatoid arthritis: a prelude.

artículo científico publicado en 2005

The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus

artículo científico publicado en 2006

The unmet need in rheumatology: Reports from the targeted therapies meeting 2017.

artículo científico publicado en 2017

The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016

artículo científico publicado en 2016

The when and how of biologic agent withdrawal in rheumatoid arthritis: learning from large randomised controlled trials

artículo científico publicado en 2013

Therapeutic blockade of TNF in patients with SLE-promising or crazy?

artículo científico publicado en 2011

Therapeutic strategies for rheumatoid arthritis

artículo científico publicado en 2003

Therapeutic strategies in early rheumatoid arthritis

artículo científico publicado en 2005

Therapy of systemic lupus erythematosus: a look into the future

artículo científico publicado en 2002

Threats to validity of observational studies on disease-modifying antirheumatic drug therapies for rheumatoid arthritis: new aspects after the fall of the pyramid and the rise of new therapeutics

artículo científico publicado en 2003

Tocilizumab

artículo científico publicado en 2009

Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction ⬇️

artículo científico publicado el 25 de noviembre de 2011

Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies

artículo científico publicado en 2016

Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group

scientific article published on 14 October 2020

Treat-to-target as an approach in inflammatory arthritis

artículo científico publicado en 2016

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.

artículo científico publicado en 2014

Treat-to-target: rationale and strategies

artículo científico publicado el 1 de julio de 2012

Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire

artículo científico publicado en 2011

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force ⬇️

artículo científico publicado en 2017

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force ⬇️

artículo científico

Treating rheumatoid arthritis to target: recommendations of an international task force

artículo científico publicado en 2010

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

artículo científico publicado en 2014

Treatment Patterns of Multimorbid Patients with Rheumatoid Arthritis: Results from an International Cross-sectional Study

artículo científico publicado en 2015

Treatment of psoriatic arthritis: management recommendations

artículo científico

Treatment of rheumatoid arthritis by TNF-blocking agents

artículo científico publicado en 2002

Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin

artículo científico publicado en 2002

Tumor necrosis factor–inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor–driven model of rheumatoid arthritis ⬇️

artículo científico publicado el 1 de marzo de 2013

Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo

artículo científico publicado en 2005

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).

artículo científico publicado en 2008

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

scientific article published on 29 October 2019

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.

artículo científico

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria

artículo científico publicado en 2018

Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritis

artículo científico publicado en 2005

Value of self-performed joint counts in rheumatoid arthritis patients near remission ⬇️

artículo científico publicado el 14 de marzo de 2012

Vitamin D receptor regulates TNF-mediated arthritis ⬇️

artículo científico publicado el 17 de marzo de 2011

What is the place of recently approved T cell-targeted and B cell-targeted therapies in the treatment of rheumatoid arthritis? Lessons from global clinical trials.

artículo científico publicado en 2007

When rheumatologists report that they agree with a guideline, does this mean that they practise the guideline in clinical practice? Results of the International Recommendation Implementation Study (IRIS).

artículo científico publicado en 2016

Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis

artículo científico publicado en 2004

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda